Sign up to receive Rapport
Rapport is our e-newsletter and online resource for sharing our expertise and experience in global healthcare market research.
The challenge
Our client markets a product for Oral Mucositis (OM) - a side effect of cancer treatment - and wanted to better understand the disease and treatment challenges faced by both patients and physicians across Asia. In addition, our client also wanted to establish KOLs to advocate for the management of OM by raising the overall disease awareness, understanding and provision of better support for the wider healthcare community. In order to achieve this our client intended to submit the research for publication in a leading medical journal.
The challenge
Our client markets a product for Oral Mucositis (OM) - a side effect of cancer treatment - and wanted to better understand the disease and treatment challenges faced by both patients and physicians across Asia. In addition, our client also wanted to establish KOLs to advocate for the management of OM by raising the overall disease awareness, understanding and provision of better support for the wider healthcare community. In order to achieve this our client intended to submit the research for publication in a leading medical journal.
Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat.
The solution
Oncologists involved in OM management and patients who had developed OM during cancer treatment were recruited from seven countries across Asia. Oncologists completed a face-to-face, quantitative interview and patients completed a face-to-face interview and a self-reported questionnaire. The aim of the research was to assess the level of concordance between the perspectives of oncologists and those of patients regarding OM symptoms, and the impact of OM on various aspects of daily living and concurrent cancer management.
The outputs
The study found that Oncologists and patients ranked treatment-induced OM among the three most important toxicities of cancer therapy requiring intervention. But while oncologists’ concerns related to the delays and interruptions of cancer treatment, patients tended to focus on the effects of OM on eating, drinking, and talking. Findings from the study were published in the ‘Supportive Care in Cancer’ journal which provides members of the Multinational Association of Supportive Care in Cancer (MASCC) and other interested parties with the most recent scientific and social information on all aspects of supportive care in cancer patients.
Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat, sed diam voluptua. At vero eos et accusam et justo duo dolores et ea rebum. Stet clita kasd gubergren, no sea takimata sanctus est Lorem ipsum dolor sit amet. Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor invidunt ut labore et dolore magna aliquyam erat.